TARGETING BAFF AND APRIL IN IGA-NEPHROPATHY

被引：0
|
作者：
Komissarov, Kirill [1 ,2 ]
Nizheharodava, Darya [3 ]
Pilotovich, V. [2 ]
Zafranskaya, Maryna [4 ]
机构：
[1] Minsk Sci Pract Ctr Surg Transplantat & Hematol, Nephrol, Renal Replacement Therapy & Kidney transplanat, Minsk, BELARUS
[2] Belarusian Med Acad Postgrad Educ, Urol & Nephrol, Minsk, BELARUS
[3] Belarusian Med Acad Postgrad Educ, Dept Sci & Res Labour, Immunol, Minsk, BELARUS
[4] Belarusian State Univ, Dept Immunol, Immunol, Int Sakharov Environm Inst, Minsk, BELARUS
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
5639
引用
收藏
页码：I399 / I400
页数：2
相关论文
共 50 条
  • [1] Targeting APRIL in the Treatment of IgA Nephropathy
    Cheung, Chee Kay
    Barratt, Jonathan
    Carroll, Kevin
    Lafayette, Richard A.
    Liew, Adrian
    Suzuki, Yusuke
    Tesar, Vladimir
    Trimarchi, Hernan
    Wong, Muh Geot
    Zhang, Hong
    Perkovic, Vlado
    Rizk, Dana V.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (03): : 394 - 398
  • [2] BAFF, APRIL Y BAFFR: DIFFERENTIAL BIOMARKERS BETWEEN IGA VASCULITIS AND IGA NEPHROPATHY?
    Prieto-Pena, D.
    Genre, F.
    Martinez, S. Remuzgo
    Pulito-Cueto, V.
    Atienza-Mateo, B.
    Sevilla, B.
    Llorca, J.
    Ortego, N.
    Leonardo, M.
    Penalba, A.
    Martin-Penagos, L.
    Fillloy, J. A. Miranda
    Narvaez, J.
    Montero, L. Caminal
    Collado, P.
    Fernandez-Nebro, A.
    Diaz-Cordoves, G.
    Cigarran, S.
    Calvino, J.
    Cobelo, C.
    De Argila, D.
    Vicente-Rabaneda, E. F.
    Rubio-Romero, E.
    Luque, M. Leon
    Blanco-Madrigal, J. M.
    Galindez-Agirregoikoa, E.
    Gualillo, O.
    Ibanez, J. Martin
    Castaneda, S.
    Blanco, R.
    Gonzalez-Gay, M. A.
    Lopez-Mejias, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1203 - 1204
  • [3] Targeting APRIL to slow progression of IgA nephropathy
    Monica Wang
    Nature Reviews Nephrology, 2024, 20 : 6 - 6
  • [4] Targeting APRIL to slow progression of IgA nephropathy
    Wang, Monica
    NATURE REVIEWS NEPHROLOGY, 2024, 20 (01) : 6 - 6
  • [5] BAFF and APRIL variants associated with susceptibility to IgA nephropathy and lupus nephritis
    Wang, Y. -N.
    Zhou, X. -J.
    Zhang, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 303 - 303
  • [6] IGA-NEPHROPATHY "(IGA-IGG-NEPHROPATHY-IGA-NEPHRITIS) - DISEASE ENTITY
    GARTNER, HV
    HONLEIN, F
    TRAUB, U
    BOHLE, A
    VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1979, 385 (01) : 1 - 27
  • [7] INCIDENCE AND CLINICAL COURSE OF IGA-NEPHROPATHY
    ZUGEHOR, M
    WILLGEROTH, C
    PAP, I
    MORENZ, J
    KEMNITZ, P
    LACHHEIN, L
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1985, 40 (13): : 969 - 972
  • [8] IgA-nephropathy:: frequent, but rarely diagnosed
    Floege, J
    Gröne, HJ
    INTERNIST, 2003, 44 (09): : 1131 - 1139
  • [9] DAPSONE TREATMENT IN PRIMARY IGA-NEPHROPATHY
    MOHACSI, G
    SONKODI, S
    HUSZ, S
    DOBOZI, A
    IVANYI, B
    ORMOS, J
    MINERAL AND ELECTROLYTE METABOLISM, 1988, 14 (2-3) : 186 - 186
  • [10] ALLERGIC DIATHESIS IN PATIENTS WITH IGA-NEPHROPATHY
    KOJIMA, H
    SATO, M
    KOSHIKAWA, S
    NEPHRON, 1989, 51 (01): : 121 - 121
12345